Latest "Texas Center Proton Therapy" News Stories

08:45 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Texas Center Proton Therapy" found in our extensive news archives from over 250 global news sources.

More Information about Texas Center Proton Therapy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Texas Center Proton Therapy for you to read. Along with our medical data and news we also list Texas Center Proton Therapy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Texas Center Proton Therapy Companies for you to search.

Showing "Texas Center Proton Therapy" News Articles 1–25 of 14,000+

Extremely Relevant

Maryland Proton Treatment Center offers thermal therapy in combination with proton therapy

(University of Maryland Medical Center) The Maryland Proton Treatment Center (MPTC) is now offering deep-tissue external thermal therapy in combination with high-precision proton-beam radiotherapy as a potential way to boost survival chances for certain cancer patients. MPTC is the only center in the world to offer these two treatments at the same facility, an advantage to patients because these t...

RaySearch Laboratories: Tsuyama Chuo Proton Beam Center, Japan, Teats First Patients With RayStation

The proton center opened in 2016 and is run jointly with Okayama University. It is equipped with Mitsubishi Electric's proton therapy system, featuring the SELECTBEAM Read more...

HCI at University of Utah selects Mevion S250i proton therapy system

U of U professor radiation oncology chair and HCI radiation oncologist Dennis Shrieve said: “The proton therapy center at HCI will bring yet another unique, technically advanced radiation The post HCI at University of Utah selects Mevion S250i proton therapy system appeared first on Compelo Medical Devices.

Problematic PR releases: As evidence lags on proton therapy, hospitals lure patients with anecdotes and high-tech appeals

A recent news release from Michigan’s Beaumont Medical Center shared the story of an 8-year-old girl with a brain tumor who traveled from Hawaii to be treated at the hospital’s proton therapy center. Its heart-warming details include how the girl bonded with her medical team, gave them candy from her home state, and hopped onto […]

Proton Therapy Market – Forecasts from 2018 to 2023 –

DUBLIN–(BUSINESS WIRE)–The “Proton Therapy Market – Forecasts from 2018 to 2023” report has been added to’s offering. The global proton therapy market is anticipated to witness a compound annual growth rate of 4.03% during the forecast period to reach … Continue reading → Cet article Proton Therapy Market – Forecasts from...

Proton Therapy Trials 'at Risk,' Slow to Enroll Patients

Is proton therapy better than standard radiotherapy in the treatment of cancer? Seven major randomized clinical trials have no answers at this point. Medscape Medical News

Tsuyama Chuo Hospital in Japan commences clinical use of RayStation

Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil beam scanning treatments at its Proton Beam Cancer Center. On 15 May, the center carried out the world’s first patient treatment using RayStation together with Mitsubishi Electric’s proton therapy system, with a plan created in RayStation 6.


Hitachi's First Dedicated Compact Proton Therapy System to be Supplied to Tokushukai Medical Group

Hitachi, Ltd. (TSE: 6501, “Hitachi”) announced today that it has received an order for the compact proton therapy system from Tokushukai Medical Group, and the system will be installed at Shonan Kamakura Advanced Medical Center, which is planned to be built near Shonan Kamakura General Hospital.

Why randomized trials for proton therapy are difficult to complete (and what we can do about it)

(University of Pennsylvania School of Medicine) Commercial insurance medical policies that do not cover treatment with proton therapy can make it difficult for patients to participate in randomized clinical trials funded by the NCI, part of the National Institutes of Health, that are evaluating the therapy.

Insurer Faces $25.5m Payout After Denial of Proton Therapy

Health insurer Aetna denied proton therapy because it was 'experimental.' This jury verdict raises the possibility that other denial-of-care suits will follow. Medscape Medical News

Proton therapy for pediatric brain tumors has favorable cognitive outcomes

(Northwestern Memorial HealthCare) Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared to x-ray radiation therapy according to a study by Northwestern Medicine.

Proton therapy for paediatric brain tumours has favourable cognitive outcomes

Proton therapy treatment for paediatric brain tumour patients is associated with better neurocognitive outcomes compared to x-ray radiation therapy according to a study presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting and...

Proton-Beam Therapy: Snags in US but Expanding Globally

While some proton-beam therapy centers in the United States have hit financial snags, the global market is growing, with centers popping up all over the map. Medscape Medical News

Varian Introduces New ProBeam 360° Proton Therapy System

PALO ALTO, Calif., Oct. 20, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced its new single-room proton therapy system, ProBeam® 360°. With a 30 percent Read more...

Siteman Cancer Center Expands Proton Therapy Center with Second Mevion Proton System

Construction has begun on the new vault that will be equipped with the Mevion HYPERSCAN Pencil Beam Scanning System Mevion Medical System announces that construction is underway for a second proton therapy system at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. This new vault will be equipped...

Cognitive Outcomes Improved With Proton Therapy in Pediatric Brain Tumors

Favorable neurocognitive outcomes were observed in pediatric patients with brain tumors with the use of proton radiation therapy compared with X-ray radiation therapy.

Ackerman Cancer Center Celebrates 1,000 Patients Treated with Proton Therapy

Since first opening its doors in April of 2015, the goal of the Proton Therapy Center at Ackerman Cancer Center was to provide patients access to the best radiation therapy possible. Just a few short years later, the center has done just that with the start of the their 1,000th patient. This press release features multimedia. View the full release here: ht...

Genprex Updates Agreement with University of Texas MD Anderson Cancer Center

Genprex (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that it has amended its agreement with The University of Texas MD Anderson Cancer Center to resume patient enrollment in its Phase I/II clinical trial evaluating the combination of the company’s investigational … Cont...

Global Proton Therapy Market Outlook 2022 [Report Updated: 11012018] Prices from USD $1050

Proton beam therapy or proton therapy, part of particle therapy is the most advanced form of radiation therapy with precise dose sculpting and efficiency. It is an external beam radiotherapy using photon ionizing radiation to irradiate tumors. It successfully eradicates sideeffects associated with other forms of conventional radiation therapies for destroying cancer cells. The proton therapy syste...

Researchers find combination can enhance ipilimumab immunotherapy

(University of Texas M. D. Anderson Cancer Center) Using a targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors, researchers at The University of Texas MD Anderson Cancer Center report today in the Journal of Clinical Investigation.

Mendelsohn shares Tang Prize for leadership in developing targeted therapy

(University of Texas M. D. Anderson Cancer Center) Targeted cancer therapy pioneer John Mendelsohn, M.D., researcher and former president of The University of Texas MD Anderson Cancer Center, will share the 2018 Tang Prize in Biopharmaceutical Science for his leadership in developing antibodies to block cancer-promoting growth factor receptors on the surface of cancer cells.

New Texas supercomputer to push the frontiers of science

(University of Texas at Austin, Texas Advanced Computing Center) The National Science Foundation announced today that it has awarded $60 million to the Texas Advanced Computing Center at the University of Texas at Austin for the acquisition and deployment of a new supercomputer that will be the fastest at any US university and among the most powerful in the world. The new system, known as Frontera...

MD Anderson study shows key enzyme linked to therapy resistance in deadly lung cancer

(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). They believe two existing therapies may hold promise for clinical studies for this deadly and ...

Mevion Raises $150 Million from China Investors for Proton Therapy Machines

Mevion Medical Systems, a Boston area maker of proton therapy machines, closed a $150 million financing led by YuanMing Capital with participation by other China-based private equity investors. Mevion said the financing provides the company with growth capital, clears existing debt and "optimizes" the shareholder structure. The company believes its proton systems offer a smaller footprint, lower o...

Suppression of DKK3 protein thwarts pancreatic tumor progression and prolongs survival

(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center have shed new light on why pancreatic tumors are so resistant to therapy. The answer may lie in treating a protein found in the scar-type tissue called stroma which often surrounds the tumors.

Quick Search


News Quicklinks